ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Tackling Maternal Health with Technology: Emagine Solutions’ Mission to Save Lives

Maternal health in the U.S. faces a critical crisis. With the country ranking as one of the most dangerous and expensive places in the developed world to give birth, the situation demands urgent solutions. Emagine Solutions Technology, led by Courtney Williams, is addressing this issue through innovative technology designed to make pregnancy safer, more affordable, and improve outcomes for both patients and providers. 

Bridging the Gaps in Maternal Health 

Emagine Solutions Technology combines three key innovations: the Journey Pregnancy app for patients, remote patient monitoring software for clinicians, and an FDA-cleared handheld ultrasound device compatible with smartphones and tablets. Together, these technologies are transforming the pregnancy care journey, enhancing communication between patients and healthcare providers while offering vital tools to monitor maternal health. 

From Personal Experience to Global Impact 

Courtney Williams’ journey into maternal health innovation began when her sister experienced a high-risk pregnancy. This personal experience revealed the dangers of pregnancy and motivated Williams to leave her corporate job in customer analytics and finance to address these challenges. Located in Arizona, one of the most dangerous states for maternal health, she recognized the urgent need for localized solutions that could also scale globally. 

Building the Dream Team 

Despite not having a background in healthcare, Williams relied on her strong networking skills and brought together a team of experts. Her co-founder, a tech professional with experience at Google and Siemens, spearheaded the engineering of the handheld ultrasound device. By assembling a robust advisory board and collaborating with medical device industry leaders, Williams ensured her vision was backed by both technological and healthcare expertise. 

Prioritizing Solutions for Maximum Impact 

The handheld ultrasound was Emagine’s first milestone. With over half the global population lacking access to radiology, this device addressed a crucial gap, enabling better monitoring of fetal development. Extensive research, supported by a National Science Foundation grant, helped refine the product based on provider feedback. The device earned FDA clearance, marking a significant step forward in democratizing access to essential healthcare tools. 

However, it was Williams’ personal experience with pre-eclampsia during her pregnancy that inspired Emagine to expand its offerings. Recognizing the disconnect between patients and providers, the team developed the Journey Pregnancy app and remote monitoring tools to bridge this gap. 

Empowering Patients Through Data 

The Journey Pregnancy app provides pregnant individuals with tools to log key health metrics such as blood pressure, glucose levels, mood, and weight. Unlike many pregnancy apps focused on entertainment, this app emphasizes actionable health insights. Features include integration with wearable devices like Fitbits and blood pressure cuffs, real-time notifications for abnormal readings, and a virtual doula to answer questions. 

By equipping patients with accessible data, the app empowers them to advocate for their health, ask better questions during appointments, and address issues proactively. This approach not only improves outcomes but also alleviates some of the burdens on overworked providers. 

Scaling the Vision 

Emagine’s technologies are already making an impact. Thousands of users have downloaded the app, and its blood pressure monitoring feature has provided critical alerts to patients, potentially saving lives. Clinics and federally qualified health centers are onboarding these tools, proving their value in real-world applications. 

Funding Innovation Through Grants 

Building a med-tech company requires significant funding, especially for regulatory compliance and software development. Williams strategically pursued non-dilutive funding through grants from organizations like the Department of Health and Human Services. This approach not only provided the necessary capital but also established credibility for the company’s innovations. 

The Road Ahead 

Emagine Solutions Technology is not just innovating—it’s saving lives. By focusing on scalable solutions that address real pain points in maternal health, the company is redefining how technology can support patients and providers alike. With a strong foundation, proven tools, and an unwavering commitment to maternal health, the future for Emagine Solutions and its mission looks brighter than ever. To hear Courtney Williams’ full journey on Women in Motion, click this link https://businessradiox.com/podcast/women-in-motion/high-risk-to-high-tech/ and visit them on TikTok, @thejourneypregnancy & Instagram, @emaginestech. 

About Women’s Business Enterprise Council-West (WBEC-West)              

WBEC-West is a regional partner of the Women’s Business Enterprise National Council (WBENC), a coalition of corporations, WBEs, and regionally focused women’s business organizations. As an affiliate organization, WBEC-West implements the certification standards of WBENC throughout Arizona, Colorado, Southern California, Utah, Wyoming, Nevada, Hawaii, and Guam. WBENC is the largest certifier of women’s business enterprises in the U.S. and a leading advocate for women business owners, leaders, and entrepreneurs. WBENC certification is nationally recognized and accepted by more than 10,000 major corporations. We also support corporations in their efforts to include WBENC Certified WBEs in their supply chain. 

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.